New ETF allows you to invest in up-and-coming Chinese biotech companies


Investors now have a way to buy into and track the up-and-coming Chinese biotechnology sector, through a new exchange-traded fund that launched on Wednesday. The sector is at a unique, even revolutionary, moment in time: already developing world-class, cutting-edge therapeutics in areas like oncology and gene therapy, and getting a boost from a variety of new policies and regulatory factors, Loncar says.



from Biotech News